David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Access to essential drugs is vital for the promotion of better health for the entire population. However, access to these essential drugs are hampered by a number of factors, most notable among which are the uneven availability of essential drugs across different areas and low capacity to pay. High prices of drugs are being used as an argument for greater government role in the drugs sector through effective regulation of the drug market. To note, there have been different programs or policies implemented in order for government to have a more active role in drug regulation. This paper explores the nuances and intricacies of drug regulation, looking at it as an issue of economic failure as well as government failure.
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library||
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Ralph Metzner (2005). Psychedelic, Psychoactive, and Addictive Drugs and States of Consciousness. In Mitch Earleywine (ed.), Mind-Altering Drugs: The Science of Subjective Experience. Oxford University Press. 25-48.
Peter R. Mansfield (2005). Banning All Drug Promotion is the Best Option Pending Major Reforms. Journal of Bioethical Inquiry 2 (2):75-81.
Sigrid Sterckx (2005). Can Drug Patents Be Morally Justified? Science and Engineering Ethics 11 (1):81-92.
Michael Huemer (2004). America's Unjust Drug War. In Bill Masters (ed.), The New Prohibition. Accurate Press.
John Sabini & John Monterosso (2005). Judgments of the Fairness of Using Performance Enhancing Drugs. Ethics and Behavior 15 (1):81 – 94.
Thomas C. Jones (2005). A Call to Restructure the Drug Development Process: Government Over-Regulation and Non-Innovative Late Stage (Phase III) Clinical Trials Are Major Obstacles to Advances in Health Care. Science and Engineering Ethics 11 (4):575-587.
Nicholas J. Caste (1992). Drug Testing and Productivity. Journal of Business Ethics 11 (4):301 - 306.
Hugh LaFollette (1994). Mandatory Drug Testing. In S. Luper & C. Brown (eds.), Drugs, Morality, and the Law. Garland.
Michael Huemer (2008). The Drug Laws Don't Work. The Philosophers' Magazine (41):71-75.
Added to index2009-05-07
Total downloads16 ( #108,626 of 1,102,136 )
Recent downloads (6 months)1 ( #306,622 of 1,102,136 )
How can I increase my downloads?